Evidence map›Paper›PMID 18729781›Full record

Trial reportThe Journal of infectious diseases2008

Repeated treatments with albendazole enhance Th2 responses to Ascaris Lumbricoides, but not to aeroallergens, in children from rural communities in the Tropics.

Philip J Cooper, Ana Lucia Moncayo, Irene Guadalupe, Susana Benitez, Maritza Vaca, Martha Chico, George E Griffin

Open access · bronzeAbstract readRandomized Controlled Trial
In one paragraph

Trial report in The Journal of infectious diseases, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.4field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 29 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Whipworm and roundworm infections.Nature reviews. Disease primers · 2020
    Review
  8. Review
  9. Review
  10. Community deworming alleviates geohelminth-induced immune hyporesponsiveness.Proceedings of the National Academy of Sciences of the United States of America · 2016
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Interactions between helminth parasites and allergy.Current opinion in allergy and clinical immunology · 2009
    Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 3 countries.

Philip J CooperCentro de Investigaciónes FEPIS, Quinindé, Ecuador. pcooper@ecnet.ec
Ana Lucia Moncayo
Irene Guadalupe
Susana Benitez
Maritza Vaca
Martha Chico
George E Griffin
CIUDAD · ECUniversidad San Francisco de Quito · EC

Funding

Wellcome Trust 074679
6 · The paper itself

Abstract

Geohelminth infections are associated with modulation of immunity to parasite antigens and aeroallergens. To investigate the possibility that this modulation is affected by anthelmintic treatment, we compared cytokine responses in children who were treated with repeated doses of albendazole over 1 year versus those in children who had were not treated. Whole-blood samples were cultured with Ascaris antigen and house dust mite and cockroach allergens, and levels of interleukin (IL)-5, IL-13, interferon-gamma, and IL-10 were measured. Anthelmintic treatment was associated with enhanced production of Th2 cytokines in response to parasite antigen but did not affect responses to aeroallergens. The data indicate that long-term treatment may be associated with increased Th2 antiparasite immunity.

Indexed as

AlbendazoleAnthelminticsRural PopulationAllergensAnimalsAscariasisAscaris lumbricoidesChildCockroachesCytokinesDustEcuadorFemaleHumansHypersensitivity, ImmediateMaleAlbendazoleAllergensAnthelminticsCytokinesDust

Identifiers

PMID18729781
PMCPMC2635537
OpenAlexW2149103470

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.